Liminal BioSciences Inc.

Liminal BioSciences Inc.verified

LMNL

Price:

$8.5

Market Cap:

$38.36M

Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and ch...[Read more]

Industry

Biotechnology

IPO Date

2009-12-18

Stock Exchange

NASDAQ

Ticker

LMNL

The Current Ratio as of November 2025 (TTM) for Liminal BioSciences Inc. (LMNL) is 4.09

According to Liminal BioSciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.09. This represents a change of 5.78% compared to the average of 3.87 of the last 4 quarters.

Liminal BioSciences Inc. (LMNL) Historical Current Ratio (quarterly & annually)

How has LMNL Current Ratio performed in the past?

The mean historical Current Ratio of Liminal BioSciences Inc. over the last ten years is 2.74. The current 4.09 Current Ratio has changed 14.84% with respect to the historical average. Over the past ten years (40 quarters), LMNL's Current Ratio was at its highest in in the June 2016 quarter at 6.65. The Current Ratio was at its lowest in in the June 2014 quarter at 0.52.

Quarterly (TTM)
Annual

Average

2.74

Median

2.52

Minimum

1.14

Maximum

6.20

Liminal BioSciences Inc. (LMNL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Liminal BioSciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 186.67%

Maximum Annual Current Ratio = 6.20

Minimum Annual Increase = -43.03%

Minimum Annual Current Ratio = 1.14

Quarterly (TTM)
Annual
YearCurrent RatioChange
20224.09-34.02%
20216.20101.86%
20203.071.20%
20193.03165.42%
20181.14-43.03%
20172.010.10%
20162.00-38.65%
20153.27186.67%
20141.14-20.20%
20131.437.80%

Liminal BioSciences Inc. (LMNL) Average Current Ratio

How has LMNL Current Ratio performed in the past?

The current Current Ratio of Liminal BioSciences Inc. (LMNL) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.45

5-year avg

3.51

10-year avg

2.74

Liminal BioSciences Inc. (LMNL) Current Ratio vs. Peers

How is LMNL’s Current Ratio compared to its peers?

Liminal BioSciences Inc.’s Current Ratio is greater than Freeline Therapeutics Holdings plc (2.18), greater than Serina Therapeutics, Inc. (2.24), greater than AnPac Bio-Medical Science Co., Ltd. (0.32), greater than LakeShore Biopharma Co., Ltd (1.02), less than Allakos Inc. (14.23), greater than Angion Biomedica Corp. (3.29), greater than Marinus Pharmaceuticals, Inc. (1.66), greater than Vincerx Pharma, Inc. (1.79), greater than Opus Genetics, Inc. (1.90), greater than Traws Pharma, Inc. (1.22),

Build a custom stock screener for Liminal BioSciences Inc. (LMNL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Liminal BioSciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Liminal BioSciences Inc. (LMNL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Liminal BioSciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Liminal BioSciences Inc.'s Current Ratio?

How is the Current Ratio calculated for Liminal BioSciences Inc. (LMNL)?

What is the highest Current Ratio for Liminal BioSciences Inc. (LMNL)?

What is the 3-year average Current Ratio for Liminal BioSciences Inc. (LMNL)?

What is the 5-year average Current Ratio for Liminal BioSciences Inc. (LMNL)?

How does the current Current Ratio for Liminal BioSciences Inc. (LMNL) compare to its historical average?